Over half of new cancer drugs ‘show no benefits’ for survival or wellbeing. Of 48 cancer drugs approved between 2009-2013, 57% of uses showed no benefits and some benefits were ‘clinically meaningless’, says BMJ study.

Of 48 cancer drugs approved between 2009-2013, 57% of uses showed no benefits and some benefits were ?clinically meaningless?, says BMJ study

https://www.theguardian.com/business/2017/oct/05/over-half-of-new-cancer-drugs-show-no-benefits-for-survival-or-wellbeing

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →